Clinical Trial: Becotatug Vedotin combined with Palbociclib for advanced head and neck squamous cell carcinoma after failure of first-line treatment (China)

Posted On: 2026-08-12

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Becotatug Vedotin combined with Palbociclib for advanced head and neck squamous cell carcinoma after failure of first-line treatment'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129847

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=325479

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Becotatug Vedotin combined with Palbociclib for advanced head and neck squamous cell carcinoma after failure of first-line treatment (China)